Abbott Laboratories 2014 Annual Report Download - page 39

Download and view the complete annual report

Please find page 39 of the 2014 Abbott Laboratories annual report below. You can navigate through the pages in the report by either clicking on the pages listed below, or by using the keyword search tool below to find specific information within the annual report.

Page out of 80

  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
  • 15
  • 16
  • 17
  • 18
  • 19
  • 20
  • 21
  • 22
  • 23
  • 24
  • 25
  • 26
  • 27
  • 28
  • 29
  • 30
  • 31
  • 32
  • 33
  • 34
  • 35
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • 47
  • 48
  • 49
  • 50
  • 51
  • 52
  • 53
  • 54
  • 55
  • 56
  • 57
  • 58
  • 59
  • 60
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • 73
  • 74
  • 75
  • 76
  • 77
  • 78
  • 79
  • 80

37
ABBOTT 2014 ANNUAL REPORT
December 31 2014 2013
Liabilities and Shareholders’ Investment
Current Liabilities:
Short-term borrowings $÷4,382 $÷3,164
Trade accounts payable 1,064 1,026
Salaries, wages and commissions 776 906
Other accrued liabilities 2,943 3,500
Dividends payable 362 341
Income taxes payable 270 175
Current portion of long-term debt 55 9
Current liabilities held for disposition 680 386
Total Current Liabilities 10,532 9,507
Long-term Debt 3,408 3,388
Post-employment Obligations and other long-term liabilities 5,588 4,784
Non-current liabilities held for disposition 108 7
Commitments and Contingencies
Shareholders’ Investment:
Preferred shares, one dollar par value — —
Authorized—1,000,000 shares, none issued
Common shares, without par value 12,383 12,048
Authorized—2,400,000,000 shares
Issued at stated capital amount
Shares: 2014: 1,694,929,949; 2013: 1,685,827,096
Common shares held in treasury, at cost— (8,678) (6,844)
Shares: 2014: 186,894,515; 2013: 137,728,810
Earnings employed in the business 22,874 21,979
Accumulated other comprehensive income (loss) (5,053) (2,012)
Total Abbott Shareholders’ Investment 21,526 25,171
Noncontrolling Interests in Subsidiaries 113 96
Total Shareholders’ Investment 21,639 25,267
$41,275 $42,953
The accompanying notes to consolidated financial statements are an integral part of this statement.
CONSOLIDATED BALANCE SHEET
(dollars inmillions)